Display options
Cite
Bruno R, Proietti A, Alì G, et al. Squamous cell transformation and . Oncol Lett. 2017;14(5):5947-5951doi: 10.3892/ol.2017.6913.
Bruno, R., Proietti, A., Alì, G., Puppo, G., Ribechini, A., Chella, A., & Fontanini, G. (2017). Squamous cell transformation and . Oncology letters, 14(5), 5947-5951. https://doi.org/10.3892/ol.2017.6913
Bruno, Rossella, et al. "Squamous cell transformation and ." Oncology letters vol. 14,5 (2017): 5947-5951. doi: https://doi.org/10.3892/ol.2017.6913
Bruno R, Proietti A, Alì G, Puppo G, Ribechini A, Chella A, Fontanini G. Squamous cell transformation and . Oncol Lett. 2017 Nov;14(5):5947-5951. doi: 10.3892/ol.2017.6913. Epub 2017 Sep 08. PMID: 29113230; PMCID: PMC5661389.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2017 Nov;14(5):5947-5951. doi: 10.3892/ol.2017.6913. Epub 2017 Sep 08.

Squamous cell transformation and .

Oncology letters

Rossella Bruno, Agnese Proietti, Greta Alì, Gianfranco Puppo, Alessandro Ribechini, Antonio Chella, Gabriella Fontanini

Affiliations

  1. Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, I-56100 Pisa, Italy.
  2. Division of Pathological Anatomy, University Hospital of Pisa, I-56100 Pisa, Italy.
  3. Division of Pneumology, University Hospital of Pisa, I-56100 Pisa, Italy.
  4. Endoscopic Section of Pneumology, University Hospital of Pisa, I-56100 Pisa, Italy.
  5. Program of Pleuropulmonary Pathology, University Hospital of Pisa, I-56100 Pisa, Italy.

PMID: 29113230 PMCID: PMC5661389 DOI: 10.3892/ol.2017.6913

Abstract

The present case report describes the infrequent coexistence of squamous cell transformation and the epidermal growth factor receptor (

Keywords: epidermal growth factor receptor; lung adenocarcinoma; resistance mechanisms; tyrosine kinase inhibitor

References

  1. J Thorac Oncol. 2016 Apr;11(4):e49-51 - PubMed
  2. J Thorac Oncol. 2010 Oct;5(10):1524-8 - PubMed
  3. Intern Med. 2015;54(19):2491-6 - PubMed
  4. Oncotarget. 2016 Mar 15;7(11):12404-13 - PubMed
  5. N Engl J Med. 2010 Jun 24;362(25):2380-8 - PubMed
  6. Urology. 1995 Jul;46(1):111-3 - PubMed
  7. J Thorac Oncol. 2015 Sep;10 (9):1240-1242 - PubMed
  8. Nat Commun. 2016 Jun 10;7:11815 - PubMed
  9. Lancet Oncol. 2012 Mar;13(3):239-46 - PubMed
  10. Cancer Sci. 2016 Mar;107(3):353-8 - PubMed
  11. Clin Cancer Res. 2013 Apr 15;19(8):2240-7 - PubMed
  12. Molecules. 2016 Nov 02;21(11): - PubMed
  13. Clin Cancer Res. 2015 Mar 15;21(6):1258-66 - PubMed
  14. Cancer Discov. 2014 Sep;4(9):1046-61 - PubMed
  15. ESMO Open. 2016 May 11;1(3):e000060 - PubMed
  16. Chin J Cancer. 2016 Mar 21;35:30 - PubMed
  17. Cell Oncol (Dordr). 2013 Jul;36(4):277-88 - PubMed
  18. Lung Cancer. 2016 Apr;94:68-73 - PubMed
  19. Nat Med. 2013 Jun;19(6):676-7 - PubMed
  20. Lancet Oncol. 2015 Jul;16(7):e342-51 - PubMed
  21. PLoS Med. 2005 Mar;2(3):e73 - PubMed
  22. Cancer J. 2015 Sep-Oct;21(5):413-24 - PubMed
  23. J Thorac Oncol. 2015 Sep;10 (9):e86-e88 - PubMed
  24. Science. 2007 May 18;316(5827):1039-43 - PubMed
  25. J Natl Compr Canc Netw. 2013 Sep 1;11(9):1040-4 - PubMed
  26. Cancer J. 2015 Sep-Oct;21(5):371-7 - PubMed
  27. Cancer Res. 2005 Oct 15;65(20):9455-62 - PubMed
  28. Sci Transl Med. 2011 Mar 23;3(75):75ra26 - PubMed
  29. Lung Cancer. 2016 Aug;98 :29-32 - PubMed
  30. Lung Cancer. 2017 Jan;103:24-26 - PubMed
  31. Oncol Lett. 2016 Nov;12 (5):4009-4012 - PubMed
  32. Lancet Oncol. 2015 Feb;16(2):141-51 - PubMed

Publication Types